Sponsored By 

company insight

Your partner in clinical research from A to Z since 1984

As a specialist for studies wordwide, the AtoZ-CRO GmbH offers a broad range of professional services and partner solutions for national and international clinical studies with pharmaceuticals and medical devices. 

SHL Group details its approach to the challenges of emerging formulations

The service comprises the planning and conduction of clinical trials in all indications, patient recruitment and monitoring of the sites. Moreover AtoZ offers pharmacovigilance as well as biometry and statistical services. Medical writing and translation are completing AtoZ’ professional appearance. Customers are small- and mid-sized pharmaceutical, biotech and medical device companies.

Due to its close partnership to Eastern Europe, AtoZ-CRO is affiliated with a leading initiator of phase I studies in Warsaw, Poland. The phase I unit is within easy reach for the subjects and in close proximity to a number of large hospitals.

As the AtoZ-CRO performs clinical studies with pharmaceuticals and medical devices, the company is not limited to an indication. Amongst the 300+ performed studies the covered indications range from dermatology, hematology, immunology and internal medicine to neurology, oncology, respiratory disease and several more.

Clinical Studies Phases 0 – IV

From its head office in Overath, Germany, AtoZ-CRO manages and coordinates clinical studies of phase 0 to IV and post-marketing studies for national and international clients all over the world.

As clinical studies will be mandatory for medical devices from 2020 onwards, AtoZ-CRO will be the perfect partner due to its extensive experience not only performing studies in pharmaceuticals but also in medical devices.

The company forms a team of highly experienced professionals and medical specialists ensuring high professional standards in clinical study management. Its services comprise the planning of clinical studies, preparation of study protocols, design and implementation of (e)CRFs and Regulatory Affairs issues.

Short-time patient recruitment

Since its founding in 1984 AtoZ-CRO formed a network of motivated local monitors and investigators all over the world. Close collaborations with leading professional, guarantee very short recruitment periods and highly motivated investigators with experienced staff at study sites.

Moreover studies in Eastern Europe offer the advantage of drug-naïve, highly compliant and motivated subjects and therefore a low drop-out rate. This leads to lower costs per patient and a significant time-reduction in meeting recruitment goals.

Worldwide monitoring

The AtoZ-CRO is not only a specialist in planning but also in conducting clinical studies. Amongst others it offers the recruitment and assessment of study centers, training of investigators and their staff, monitoring the study centers incl. source data check as well as reporting, communication with investigators and the sponsor and supplying the study centers with study supplies and documentation.

Pharmacovigilance

The collating, processing, analyzing and notifying of ADRs during clinical studies is key and one of AtoZ’ competences. The submission of SUSARs and ICSR to European Regulatory Authorities and CECs is done as well as the specialization as an EMA certified safety monitoring for E2B submissions of SUSARs and ICSRs. Medical, clinical and safety regulatory affairs in the EU and a 24-hour physician stand-by service is included as well. Two AtoZ’ employees are certified and empowered to take care of any issue regarding the Pharmacovigilance such as LQPPV.

Biometry and Statistics

To successfully complete a study, AtoZ-CRO offers its Biometry and Statistics services through a long lasting and reliable partner. Amongst others, data collation, validation, analysis and report, including sequential collation and analysis are the main activities.

Quality Management

The company has its own quality management department. Independent audits of study documents (clinical study protocol, subject information sheet/informed consent form, case report form, clinical study report), investigator sites, database and Trial Master Files can be conducted as well as external supplier audits (including special service providers such as IVRS, ECG, clinical trial supply chain management) and internal system audits.

Medical Translation, Medical Writing and much more!

Moreover the AtoZ-CRO offers additional services such as Medical Translation and Medical Writing. Trainings and Seminars (ICH-GCP Basic & Refresher Training for Investigators, Study Nurses and CRAs, Basic Monitoring Training and Communication in Clinical Trials Seminar) can be offered as well.

Company history

Founded in 1984, Dr. Karl-Peter Klein took over as Managing and Medical Director of AtoZ-CRO in February 2007 and led the activities of the company to new dimensions. Based on the company’s long-established international experience in clinical trial management and cooperation with high-rated business partners, AtoZ-CRO is proud to offer a broad range of services covering all clinical research needs, in particular for small and mid-sized pharmaceutical, biotech, and medical device companies, from the planning stages to the final integrated study report.

Share this article

Go to article: Home | Deep Space DiagnosticsGo to article: In this issueGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: Contents Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Critical Software Company Insight Go to article: Critical SoftwareGo to article: NewsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Omnitron Go to article: The Medical Industry Briefing Go to article: Sab BroeckskesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Exceeding expectations: home sperm testing in the fertility tech marketGo to article: Siemens Company Insight Go to article: Siemens Go to article: Micro Systems TechnologiesGo to article: Space simulation: how gaming tech is being used to medically train astronautsGo to article: Braxton Manufacturing Go to article: CaelesteGo to article: Duodenoscopes: a dirty problemGo to article: Nelson Labs Company InsightGo to article: Nelson Labs Go to article: Mobile mind control: material engineering meets neurobiology Go to article: Abbott & CoGo to article: IMT Company InsightGo to article: IMTGo to article: Breathe easy: improving at-home asthma managementGo to article: Erdmann Design Company Insight Go to article: Erdmann Design Go to article: Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-GillGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Roundtable: debating the benefits of the NHS’s newly launched AI labGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: The long road to reliable organ printingGo to article: SartoriusGo to article: Cap BiomaterialsGo to article: URGENT/11 vulnerabilities showcase cybersecurity risks for connected medical devicesGo to article: Telemed Company InsightGo to article: TelemedGo to article: Admedus turns focus to TAVR market with next-generation tissue technologyGo to article: Turck Duotec Company Insight Go to article: Turck DuotecGo to article: 3BYGo to article: Medtronic’s extravascular ICD is pushing innovationGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Obstacle course for sperm is helping IVF scientists find the best swimmersGo to article: MicronovaGo to article: ARPA Company InsightGo to article: ARPAGo to article: Varian enters the embolisation particles marketGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Verdict Insights: The latest verdict insight from Medical Technology Go to article: TEN MedPrint Company Insight Go to article: TEN MedPrint Go to article: Future of healthcare: What will medicine look like in 2040?Go to article: GF Machining Solutions Company InsightGo to article: GF Machining Solutions Go to article: 3D printing: Bringing assistive technology to the developing worldGo to article: iTAC Software Go to article: CarmoGo to article: Stepping up anatomical 3D printingGo to article: Key Plastics Company Insight Go to article: Key PlasticsGo to article:  Coaxial Electrospinning: Revolutionising MedicineGo to article: SARA: The robot targeting European elderly careGo to article: ClippardGo to article: Bright PlasticsGo to article: Asahi InteccGo to article: Bias in the system: the leading healthcare algorithm with bias against black patientsGo to article: Mdeg Digital Go to article: Maraca InternationalGo to article: OptelGo to article: Body cameras: The benefits in mental healthcareGo to article: CleanControlling MedicalGo to article: Abatek InternationalGo to article: XavitechGo to article: Take a seat: The mental health chatbots encroaching on the therapist’s couchGo to article: mdi ConsultantsGo to article: MK FluidicsGo to article: AI for sight: The technology transforming infant eye disorder diagnosisGo to article: ProByLas Go to article: ITV Denkendorf ProduktserviceGo to article: Deals in brief powered by GlobalDataGo to article: TS Quality & EngineeringGo to article: Mi3 Medical IntelligenceGo to article: The key list powered by GlobalDataGo to article: AerogelexGo to article: EventsGo to article: PI CeramicGo to article: Next issueGo to article: Qmedics Company Insight Go to article: QmedicsGo to article: Tresky